Arrigo F.G. Cicero
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 64
- Diabetes Treatment and Management 42
- Nephrology top 0.2%
- Gout, Hyperuricemia, Uric Acid 36
- Biochemistry top 0.2%
- Pharmacology top 0.1%
- Pharmacology and Obesity Treatment 40
- Molecular Medicine top 0.5%
-
- Lipoproteins and Cardiovascular Health 97
-
- Blood Pressure and Hypertension Studies 61
-
- Metabolism, Diabetes, and Cancer 38
-
- Microbial Metabolism and Applications 35
Arrigo F.G. Cicero
558 papers receiving 16.4k citations
Peers
Comparison fields: 5 of 176
- Endocrinology, Diabetes and Metabolism 4.0k
- Nephrology 1.4k
- Biochemistry 1.0k
- Pharmacology 1.4k
- Molecular Medicine 683
Countries citing papers authored by Arrigo F.G. Cicero
This map shows the geographic impact of Arrigo F.G. Cicero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arrigo F.G. Cicero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arrigo F.G. Cicero more than expected).
Fields of papers citing papers by Arrigo F.G. Cicero
This network shows the impact of papers produced by Arrigo F.G. Cicero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arrigo F.G. Cicero. The network helps show where Arrigo F.G. Cicero may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Arrigo F.G. Cicero, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2026 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 4 | |
| 6 | 2024 | 6 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 3 | |
| 9 | 2023 | 10 | |
| 10 | 2023 | 13 | |
| 11 | 2023 | 7 | |
| 12 | 2023 | 7 | |
| 13 | 2022 | 2 | |
| 14 | 2022 | 17 | |
| 15 | 2019 | 6 | |
| 16 | 2016 | 82 | |
| 17 | 2013 | 10 | |
| 18 | A prospective evaluation of persistence on antihypertensive treatment with different antihypertensive drugs in clinical practice | 2007 | 19 |
| 19 | Practical guidelines for familial combined hyperlipidemia diagnosis: an up-date | 2007 | 38 |
| 20 | 2005 | 21 |
About Arrigo F.G. Cicero
Arrigo F.G. Cicero is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Biochemistry, having authored 581 papers that have together received 16.9k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (97 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (64 papers), Blood Pressure and Hypertension Studies (61 papers), Diabetes Treatment and Management (42 papers), Pharmacology and Obesity Treatment (40 papers), Metabolism, Diabetes, and Cancer (38 papers), Gout, Hyperuricemia, Uric Acid (36 papers) and Microbial Metabolism and Applications (35 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (4.0k citations), Nephrology (1.4k citations) and Biochemistry (1.0k citations). Arrigo F.G. Cicero has collaborated with scholars based in Italy, United States and Iran. Frequent co-authors include Claudio Borghi, Federica Fogacci, Giuseppe Derosa, Alessandro Colletti, Amirhossein Sahebkar, A. Gaddi, Sibel Ertek, Angela D’Angelo, Pamela Maffioli and Maciej Banach. Their work appears in journals such as Nutrients, Archives of Medical Science, Journal of Hypertension, Nutrition Metabolism and Cardiovascular Diseases and Journal of Clinical Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.